Literature DB >> 23649938

Ataxia-telangiectasia-mutated protein expression with microsatellite instability in gastric cancer as prognostic marker.

Jin Won Kim1, Seock-Ah Im, Min A Kim, Hyun Jin Cho, Dae Won Lee, Kyung-Hun Lee, Tae-Yong Kim, Sae-Won Han, Do-Youn Oh, Hyuk-Joon Lee, Tae-You Kim, Han-Kwang Yang, Woo Ho Kim, Yung-Jue Bang.   

Abstract

The prognostic significance of ataxia-telangiectasia-mutated (ATM) expression in gastric cancer remains unclear. The functional loss of ATM gene exhibits a biologic correlation with microsatellite instability (MSI). In this study, we investigated the significance of ATM expression with MSI by evaluating gastric cancer patients who had underwent curative resection. ATM expression was classified into low ATM expression (-, ±, +) and high ATM expression (++, +++) using immunohistochemistry analysis. MSI status was classified as MSI-negative (MSS, MSI-low) and MSI-positive (MSI-high). Of 321 patients, 205 (63.9%) exhibited low ATM expression and 116 (36.1%) exhibited high ATM expression. Low ATM expression was more frequently identified in patients of older age, more advanced stage and with MSI-positive tumor (p = 0.025, p = 0.001 and p = 0.014, respectively). The probability of 5-year disease-free survival (DFS) and overall survival (OS) was lower in low ATM expression group compared with the high ATM expression group (DFS: 62.5%, 76.4%, p = 0.017, OS: 65.9%, 78.5%, p = 0.027, respectively). According to MSI status, a subgroup of MSI-negative and low ATM expression cases exhibited the worst prognosis for DFS and OS; this subgroup also exhibited poorer DFS according to multivariable analysis (hazard radio = 1.8, 95% confidence interval, 1.2-2.8, p = 0.010), although prognostic value of ATM expression alone did not remain in the multivariable analysis. Taken together, these findings indicate that ATM expression with MSI status is an independent factor for gastric cancer prognosis in gastric cancer patients who received curative surgery.
© 2013 UICC.

Entities:  

Keywords:  adjuvant; ataxia-telangiectasia-mutated; gastric cancer; microsatellite instability; prognosis

Mesh:

Substances:

Year:  2013        PMID: 23649938     DOI: 10.1002/ijc.28245

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  24 in total

1.  Linking ATM Promoter Methylation to Cell Cycle Protein Expression in Brain Tumor Patients: Cellular Molecular Triangle Correlation in ATM Territory.

Authors:  P Mehdipour; F Karami; Firouzeh Javan; M Mehrazin
Journal:  Mol Neurobiol       Date:  2014-08-27       Impact factor: 5.590

2.  DNA Damage Repair Inhibitor for Breast Cancer Treatment.

Authors:  Ahrum Min; Kyung-Hun Lee; Seock-Ah Im
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  PARP inhibitors target ATM+p53-defective gastric cancer.

Authors:  Nicola J Curtin
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

4.  ATM Expression as a Prognostic Marker in Patients With Advanced Biliary Tract Cancer Treated With First-line Gemcitabine and Platinum Chemotherapy.

Authors:  Hyera Kim; Seung Tae Kim; Kwai Han Yoo; Jung Yong Hong; Young Suk Park; Ho Yeong Lim; Joon Oh Park
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

5.  Ataxia telangiectasia mutated (ATM), could it be another useful biomarker for the successful treatment with the poly (ADP-ribose) polymerase inhibitor?

Authors:  Suk-Young Lee; Sang Cheul Oh
Journal:  Transl Gastroenterol Hepatol       Date:  2016-03-16

6.  PD-L1 and immune infiltrates are differentially expressed in distinct subgroups of gastric cancer.

Authors:  H K Angell; J Lee; K-M Kim; K Kim; S-T Kim; S H Park; W K Kang; A Sharpe; J Ogden; A Davenport; D R Hodgson; J C Barrett; E Kilgour
Journal:  Oncoimmunology       Date:  2018-12-10       Impact factor: 8.110

7.  ATM may be a protective factor in endometrial carcinogenesis with the progesterone pathway.

Authors:  Weiwei Shan; Chao Wang; Zhenbo Zhang; Xuezhen Luo; Chengcheng Ning; Yinhua Yu; Youji Feng; Chao Gu; Xiaojun Chen
Journal:  Tumour Biol       Date:  2015-01-22

8.  Prognostic relevance of ATM protein in uveal melanoma and its association with clinicopathological factors.

Authors:  Jayanti Jha; Mithalesh Kumar Singh; Lata Singh; Neelam Pushker; Mandeep Singh Bajaj; Seema Sen; Seema Kashyap
Journal:  Int J Clin Oncol       Date:  2019-08-03       Impact factor: 3.402

9.  High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers.

Authors:  Matteo Fassan; Michele Simbolo; Emilio Bria; Andrea Mafficini; Sara Pilotto; Paola Capelli; Maria Bencivenga; Sara Pecori; Claudio Luchini; Diogo Neves; Giona Turri; Caterina Vicentini; Licia Montagna; Anna Tomezzoli; Giampaolo Tortora; Marco Chilosi; Giovanni De Manzoni; Aldo Scarpa
Journal:  Gastric Cancer       Date:  2013-11-23       Impact factor: 7.370

10.  Low ATM expression and progression-free and overall survival in advanced gastric cancer patients treated with first-line XELOX chemotherapy.

Authors:  Samuel J Klempner; Munveer S Bhangoo; Hubert Y Luu; Seung Tae Kim; Joseph Chao; Kyoung-Mee Kim; Jeeyun Lee
Journal:  J Gastrointest Oncol       Date:  2018-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.